- Home
- / Source Bioscience
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Source Bioscience financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Revenue
£13.6 M
FY, 2017
CreditSafe Score
?
Score changed on Jun 24, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| GBP | FY, 2015 | FY, 2016 | FY, 2017 |
|---|---|---|---|
| Revenue | 15.6M | 14.7M | 13.6M |
| Revenue growth, % | 4.0% | -5.4% | -7.8% |
| Cost of goods sold | 8.4M | 8.0M | 8.2M |
| Gross profit | 7.2M | 6.8M | 5.4M |
| Gross profit margin, % | 46.3% | 46.0% | 39.6% |
| Operating expense total | 4.6M | 6.0M | 8.8M |
| EBITDA | 3.7M | 1.9M | (1.5M) |
| EBITDA margin, % | 23.9% | 12.7% | -11.4% |
| EBIT | 2.6M | 738.0K | (3.4M) |
| EBIT margin, % | 16.8% | 5.0% | -24.9% |
| Pre tax profit | 883.0K | (1.1M) | (5.4M) |
| Income tax expense | 181.0K | (201.0K) | (103.0K) |
| Net Income | 702.0K | (922.0K) | (5.3M) |